| 硫糖铝口服混悬凝胶 | Laboratorio Italiano Biochimico Farmaceutico Lisapharma S.p.A. | 5ml:1g | ELEMENTIS PHARMA GmbH（灌装前制剂的生产以及中间体控制）；ZETA FARMACEUTICI S.p.A.（初级包装） | 国药准字HJ20250052 | 2025-04-22 | 查看 |
| 注射用双羟萘酸帕瑞肽微球 | Recordati Rare Diseases | 40mg（按C₅₈H₆₆N₁₀O₉计） | Recordati AG Rare Diseases Branch（生产注射用粉末半成品）；Novartis Pharmaceutical Manufacturing GmbH(制剂的初级包装)；Synergy Health Däniken AG（灭菌） | 国药准字HJ20250049 | 2025-04-22 | 查看 |
| 注射用双羟萘酸帕瑞肽微球 | Recordati Rare Diseases | 60mg（按C₅₈H₆₆N₁₀O₉计） | Recordati AG Rare Diseases Branch（生产注射用粉末半成品）；Novartis Pharmaceutical Manufacturing GmbH(制剂的初级包装)；Synergy Health Däniken AG（灭菌） | 国药准字HJ20250050 | 2025-04-22 | 查看 |
| 注射用双羟萘酸帕瑞肽微球 | Recordati Rare Diseases | 20mg（按C₅₈H₆₆N₁₀O₉计） | Recordati AG Rare Diseases Branch（生产注射用粉末半成品）；Novartis Pharmaceutical Manufacturing GmbH(制剂的初级包装)；Synergy Health Däniken AG（灭菌） | 国药准字HJ20250048 | 2025-04-22 | 查看 |
| 他达拉非片 | M/s Cipla Ltd. | 20mg | M/s Cipla Ltd. | 国药准字HJ20250051 | 2025-04-22 | 查看 |
| 纳武利尤单抗注射液 | Bristol-Myers Squibb Pharma EEIG | 40mg/4ml(10mg/ml) | Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company | 国药准字SJ20180014 | 2025-04-22 | 查看 |
| 波生坦片 | Mylan S.p.A. | 125mg（以C₂₇H₂₉N₅O₆S计） | Mylan Laboratories Ltd | 国药准字HJ20250019 | 2025-04-21 | 查看 |
| 波生坦片 | Mylan S.p.A. | 62.5mg（以C₂₇H₂₉N₅O₆S计） | Mylan Laboratories Ltd | 国药准字HJ20250018 | 2025-04-21 | 查看 |
| 螨变应原皮肤点刺试剂盒 | ALK-Abello A/S | 2ml/瓶 | ALK-ABELLO, S.A. | 国药准字SJ20150031 | 2025-04-21 | 查看 |
| 利鲁唑片 | Kenton Chemicals and Pharmaceuticals Corporation | 50mg | Standard Chem.& Pharm. Co., Ltd. | 国药准字HJ20250042 | 2025-04-17 | 查看 |
| 阿利西尤单抗注射液 | Sanofi Winthrop Industrie | 1.0mL:75mg预充式注射器 | SANOFI WINTHROP INDUSTRIE | 国药准字SJ20255002 | 2025-04-16 | 查看 |
| 米氮平片 | MYLAN LABORATORIES LIMITED | 15mg | MYLAN LABORATORIES LIMITED | 国药准字HJ20250045 | 2025-04-15 | 查看 |
| 卡匹色替片 | AstraZeneca UK Limited | 160mg | AstraZeneca AB | 国药准字HJ20250046 | 2025-04-15 | 查看 |
| 米氮平片 | MYLAN LABORATORIES LIMITED | 30mg | MYLAN LABORATORIES LIMITED | 国药准字HJ20250044 | 2025-04-15 | 查看 |
| 瑞利珠单抗注射液 | Alexion Europe SAS | 300 mg（3 mL）/瓶 | Alexion Pharma International Operations Limited, Alexion Athlone Manufacturing Facility (AAMF) | 国药准字SJ20250015 | 2025-04-15 | 查看 |
| 瑞利珠单抗注射液 | Alexion Europe SAS | 1100 mg（11 mL）/瓶 | Alexion Pharma International Operations Limited, Alexion Athlone Manufacturing Facility (AAMF) | 国药准字SJ20250016 | 2025-04-15 | 查看 |
| 氨磺必利口服溶液 | SYRI LIMITED | 60ml:6g | SYRI LIMITED | 国药准字HJ20250043 | 2025-04-15 | 查看 |
| 卡匹色替片 | AstraZeneca UK Limited | 200mg | AstraZeneca AB | 国药准字HJ20250047 | 2025-04-15 | 查看 |
| 达格列净片 | Hetero Labs Limited | 5mg（按C₂₁H₂₅ClO₆计） | Hetero Labs Limited | 国药准字HJ20250029 | 2025-04-15 | 查看 |
| 达格列净片 | Hetero Labs Limited | 10mg（按C₂₁H₂₅ClO₆计） | Hetero Labs Limited | 国药准字HJ20250030 | 2025-04-15 | 查看 |
